4Mucci LA,Kuper HE,Tamimi R,et al.Age at menarche and age at menopause in relation to hepatocellular carcinoma in women.BJOG,2001,108(3):291-294.
5Kim YI,Ki HS,Kim MH,et al.Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma.Korean J Hepatol,2009,15(2):148-158.
6Jang JS,Kim HS,Shin WG,et al.Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.J Med Virol,2009,81(9):1531-1538.
7Li D,Mallory T,Satomura S.AFP-L3:a new generation of tumor marker for hepatocellular carcinoma.Clin Chim Acta,2001,313(1-2):15-19.
8Jingting J,Changping W,Ning X,et al.Clinical evaluation of serum alpha-feto ptotein-IgM immune complexes on the diagnosis of primary hepatocelluar carcinoma.J Clin Lab Anal,2009,23(4):213-218.
9Cobey FC,Salem RR.A review of liver masses in pregnancy and aproposed algorithm for their diagnosis and management.American Journal of Surgery,2004,187(2):181-191.
10Mazzaferro V,Regalia E,Doci R,etal.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrsosis.N.Eng J Med,1996,334(11):728-729.
